Jeff Aronin was one of those few persons who, early in their life, found their passion. Their meaning for existing … His was healthcare. People and their quality of life. And, for over two decades, he has helped lead the way in bio technology in the healthcare profession.
In the year 2000, he founded Ovation Pharmaceuticals which was headquartered in Deerfield, Illinois. The company specialized in the development of medicines for small number patient populations. Some of the companies most commendable medicines are: Desoxyn and Vigabatrin (Sabril). He held the position of Chief Executive Officer. And, in 2009, Ovation Pharmaceuticals was purchased by Lundbeck, which is based out of Copenhagen, Denmark, for a total of $900,000,000. Jeff Aronin was once again appointed CEO, and President, to oversee the transition of ownership.
Since then, Jeff Aronin founded, and has been serving as CEO and Chairman at Paragon Biosciences. The company strongly believes in the doctor-patient relationship to ensure that each patient receives the best care and treatment possible. This type of practice is near, and dear, to the heart of Jeff Aronin who focuses strongly on fulfilling the needs of patients who have diseases currently without treatment methods or medicines as well as those with less-than-desirable treatment options. His patient specific medicinal development is what has driven him to the level of success he now enjoys today. This includes the development of more than 13 life-changing medicines, as well as having all them approved. And that is quite the achievement since that number can only be rivaled by large pharmaceutical companies.
Jeff Aronin and Paragon Biosciences also strongly believe in, and support, the startups of healthcare companies. They support those who want to break through and create new, highly effective ways to treat and care for their patients. This is the ultimate goal: Raising the bar for healthcare and making sure each and every individual patient is given the best chance for recovery and a better quality of life.